- Home
- ANGO vs JRS Comparison
ANGO vs JRS Comparison
Compare ANGO & JRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANGO
- JRS
- Stock Information
- Founded
- ANGO 1988
- JRS 2001
- Country
- ANGO United States
- JRS United States
- Employees
- ANGO N/A
- JRS N/A
- Industry
- ANGO Medical/Dental Instruments
- JRS Finance/Investors Services
- Sector
- ANGO Health Care
- JRS Finance
- Exchange
- ANGO Nasdaq
- JRS Nasdaq
- Market Cap
- ANGO 279.1M
- JRS 267.5M
- IPO Year
- ANGO 2004
- JRS N/A
- Fundamental
- Price
- ANGO $10.33
- JRS $8.62
- Analyst Decision
- ANGO Strong Buy
- JRS
- Analyst Count
- ANGO 3
- JRS 0
- Target Price
- ANGO $13.00
- JRS N/A
- AVG Volume (30 Days)
- ANGO 606.8K
- JRS 86.6K
- Earning Date
- ANGO 04-03-2025
- JRS 01-01-0001
- Dividend Yield
- ANGO N/A
- JRS 8.87%
- EPS Growth
- ANGO N/A
- JRS N/A
- EPS
- ANGO N/A
- JRS N/A
- Revenue
- ANGO $286,498,000.00
- JRS N/A
- Revenue This Year
- ANGO N/A
- JRS N/A
- Revenue Next Year
- ANGO $6.63
- JRS N/A
- P/E Ratio
- ANGO N/A
- JRS N/A
- Revenue Growth
- ANGO N/A
- JRS N/A
- 52 Week Low
- ANGO $5.26
- JRS $5.95
- 52 Week High
- ANGO $13.50
- JRS $8.00
- Technical
- Relative Strength Index (RSI)
- ANGO 42.75
- JRS 49.64
- Support Level
- ANGO $10.13
- JRS $8.55
- Resistance Level
- ANGO $11.07
- JRS $8.69
- Average True Range (ATR)
- ANGO 0.40
- JRS 0.12
- MACD
- ANGO -0.16
- JRS 0.01
- Stochastic Oscillator
- ANGO 14.18
- JRS 73.33
About ANGO AngioDynamics Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.
About JRS Nuveen Real Estate Income Fund of Beneficial Interest
Nuveen Real Estate Income Fund is a diversified closed-end investment company. The Fund invests primarily in income-producing common stocks, preferred stocks, convertible preferred stocks, and debt securities issued by real estate companies. At least 75% of the Fund's managed assets will be in securities rated investment grade.